These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 15883282

  • 1. Cyclosporine vs tacrolimus therapy for posterior and intermediate uveitis.
    Murphy CC, Greiner K, Plskova J, Duncan L, Frost NA, Forrester JV, Dick AD.
    Arch Ophthalmol; 2005 May; 123(5):634-41. PubMed ID: 15883282
    [Abstract] [Full Text] [Related]

  • 2. CD69 expression on peripheral CD4+ T cells parallels disease activity and is reduced by mycophenolate mofetil therapy in uveitis.
    Kilmartin DJ, Fletcher ZJ, Almeida JA, Liversidge J, Forrester JV, Dick AD.
    Invest Ophthalmol Vis Sci; 2001 May; 42(6):1285-92. PubMed ID: 11328741
    [Abstract] [Full Text] [Related]

  • 3. Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine.
    Sloper CM, Powell RJ, Dua HS.
    Ophthalmology; 1999 Apr; 106(4):723-8. PubMed ID: 10201592
    [Abstract] [Full Text] [Related]

  • 4. Noninfectious uveitis: a scarcity of randomized clinical trials.
    Okada AA.
    Arch Ophthalmol; 2005 May; 123(5):682-3. PubMed ID: 15883289
    [No Abstract] [Full Text] [Related]

  • 5. Interferon-alpha: a key factor in autoimmune disease?
    Plskova J, Greiner K, Muckersie E, Duncan L, Forrester JV.
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3946-50. PubMed ID: 16936109
    [Abstract] [Full Text] [Related]

  • 6. Validity of using vision-related quality of life as a treatment end point in intermediate and posterior uveitis.
    Murphy CC, Greiner K, Plskova J, Frost NA, Forrester JV, Dick AD.
    Br J Ophthalmol; 2007 Feb; 91(2):154-6. PubMed ID: 16973657
    [Abstract] [Full Text] [Related]

  • 7. Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series.
    Nussenblatt RB, Peterson JS, Foster CS, Rao NA, See RF, Letko E, Buggage RR.
    Ophthalmology; 2005 May; 112(5):764-70. PubMed ID: 15878055
    [Abstract] [Full Text] [Related]

  • 8. Tacrolimus (FK506) in failed cyclosporin A therapy in endogenous posterior uveitis.
    Kilmartin DJ, Forrester JV, Dick AD.
    Ocul Immunol Inflamm; 1998 Jun; 6(2):101-9. PubMed ID: 9689640
    [Abstract] [Full Text] [Related]

  • 9. Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitis.
    Murphy CC, Greiner K, Plskova J, Duncan L, Frost A, Isaacs JD, Rebello P, Waldmann H, Hale G, Forrester JV, Dick AD.
    Arch Ophthalmol; 2004 Jun; 122(6):845-51. PubMed ID: 15197059
    [Abstract] [Full Text] [Related]

  • 10. Immune monitoring with a lymphocyte adenosine triphosphate assay in kidney transplant recipients treated with a calcineurin inhibitor.
    Sugiyama K, Tsukaguchi M, Toyama A, Satoh H, Saito K, Nakagawa Y, Takahashi K, Tanaka S, Onda K, Hirano T.
    Exp Clin Transplant; 2014 Jun; 12(3):195-9. PubMed ID: 24907718
    [Abstract] [Full Text] [Related]

  • 11. [Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis].
    Greiner K, Varikkara M, Santiago C, Forrester JV.
    Ophthalmologe; 2002 Sep; 99(9):691-4. PubMed ID: 12219257
    [Abstract] [Full Text] [Related]

  • 12. Cyclosporine versus tacrolimus maintenance therapy in renal transplant.
    Alghamdi S, Nabi Z, Skolnik E, Alkorbi L, Albaqumi M.
    Exp Clin Transplant; 2011 Jun; 9(3):170-4. PubMed ID: 21649564
    [Abstract] [Full Text] [Related]

  • 13. Anti-TNFalpha therapy modulates the phenotype of peripheral blood CD4+ T cells in patients with posterior segment intraocular inflammation.
    Greiner K, Murphy CC, Willermain F, Duncan L, Plskova J, Hale G, Isaacs JD, Forrester JV, Dick AD.
    Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):170-6. PubMed ID: 14691170
    [Abstract] [Full Text] [Related]

  • 14. A randomized trial of tacrolimus versus tacrolimus and prednisone for the maintenance of disease remission in noninfectious uveitis.
    Lee RW, Greenwood R, Taylor H, Amer R, Biester S, Heissigerova J, Forrester JV, Dick AD.
    Ophthalmology; 2012 Jun; 119(6):1223-30. PubMed ID: 22381809
    [Abstract] [Full Text] [Related]

  • 15. Serum cholesterol changes in long-term survivors of liver transplantation: a comparison between cyclosporine and tacrolimus therapy.
    Charco R, Cantarell C, Vargas V, Capdevila L, Lázaro JL, Hidalgo E, Murio E, Margarit C.
    Liver Transpl Surg; 1999 May; 5(3):204-8. PubMed ID: 10226111
    [Abstract] [Full Text] [Related]

  • 16. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis.
    Lowder C, Belfort R, Lightman S, Foster CS, Robinson MR, Schiffman RM, Li XY, Cui H, Whitcup SM, Ozurdex HURON Study Group.
    Arch Ophthalmol; 2011 May; 129(5):545-53. PubMed ID: 21220619
    [Abstract] [Full Text] [Related]

  • 17. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
    Skalicka B, Kubanek M, Malek I, Vymetalova Y, Hoskova L, Podzimkova M, Kautzner J.
    J Heart Lung Transplant; 2009 Jun; 28(6):598-604. PubMed ID: 19481021
    [Abstract] [Full Text] [Related]

  • 18. Cyclosporine therapy for severe sight-threatening uveitis in children and adolescents.
    Walton RC, Nussenblatt RB, Whitcup SM.
    Ophthalmology; 1998 Nov; 105(11):2028-34. PubMed ID: 9818601
    [Abstract] [Full Text] [Related]

  • 19. Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation.
    Treede H, Glanville AR, Klepetko W, Aboyoun C, Vettorazzi E, Lama R, Bravo C, Knoop C, Aubert JD, Reichenspurner H, European and Australian Investigators in Lung Transplantation.
    J Heart Lung Transplant; 2012 Aug; 31(8):797-804. PubMed ID: 22554673
    [Abstract] [Full Text] [Related]

  • 20. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA.
    Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.